Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?

作者: Meora Feinmesser , Marisa Halpern , Eyal Fenig , Cohava Tsabari , Emmilia Hodak

DOI: 10.1016/S0046-8177(99)90070-9

关键词:

摘要: Chemotherapy and radiation therapy act predominantly through the induction of apoptosis in malignancies. Merkel cell carcinoma, an aggressive malignancy with prominent apoptosis, has proved to be sensitive both modes a certain degree. We used immunohistochemical methods examine 25 carcinomas 8 their lymph node metastases assess status antiapoptotic gene bcl-2 2 proapoptotic genes, wild-type p53 bax. All tumors showed bax immunopositivity; 76% were positive for bcl-2, only 28% p53, latter presumably reflecting mutated p53. No statistically significant relationship was found between tumor immunopositivity response or survival. The widespread apparently low rate mutations, as suggested by immunopositivity, may related presence carcinoma. finding suggests that some cells resistant apoptosis-inducing agents.

参考文章(36)
S J Korsmeyer, Bcl-2: an antidote to programmed cell death. Cancer surveys. ,vol. 15, pp. 105- 118 ,(1992)
Shinichi Kitada, Maryla Krajewska, Jurgita Sauvageot, Ahmed Shabaik, Stanislaw Krajewski, Jonathan I. Epstein, John C. Reed, Ki Song, Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. American Journal of Pathology. ,vol. 148, pp. 1567- 1576 ,(1996)
Dan A. Liebermann, Maryla Krajewska, Stanislaw Krajewski, Hong Gang Wang, Barbara Hoffman, John C. Reed, H. K. Lin, Toshiyuki Miyashita, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene. ,vol. 9, pp. 1799- 1805 ,(1994)
Désirée Ratner, Bruce R. Nelson, Marc D. Brown, Timothy M. Johnson, Merkel cell carcinoma Journal of the American Academy of Dermatology. ,vol. 29, pp. 143- 156 ,(1993) , 10.1016/0190-9622(93)70159-Q
Eyal Fenig, Hedwig Lurie, Aaron Sulkes, The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. American Journal of Clinical Oncology. ,vol. 16, pp. 54- 57 ,(1993) , 10.1097/00000421-199302000-00014
John F. R. Kerr, Clay M. Winterford, Brian V. Harmon, Apoptosis. Its significance in cancer and cancer Therapy Cancer. ,vol. 73, pp. 2013- 2026 ,(1994) , 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J
Scott W. Lowe, H.Earl Ruley, Tyler Jacks, David E. Housman, p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell. ,vol. 74, pp. 957- 967 ,(1993) , 10.1016/0092-8674(93)90719-7
R. P. TAKES, A. J. M. BALM, B. M. LOFTUS, G. BARIS, F. J. M. HILGERS, R. T. GREGOR, Merkel cell carcinoma of the head and neck. Clinical Otolaryngology. ,vol. 19, pp. 222- 229 ,(1994) , 10.1111/J.1365-2273.1994.TB01219.X